Omnia Health is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Webinars and Reports

Beckman Coulter Webinar – Fighting the Pandemic through Mass Testing

Summarizing the role of different diagnostic tests during the current global wave of COVID-19.

The Coronavirus Disease 2019 (COVID-19), caused by the novel coronavirus strain, known as the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), emerged in 2019 and in March 11th, 2020 - The WHO declares the novel coronavirus outbreak to be a pandemic. Since that date, hundreds of molecular tests and immunoassays were rapidly developed, even though many others still await clinical validation and approval.

At this time of the pandemic, there is a need for global solidarity towards test access for the rapid detection of patients. This webinar summarizes the role of different diagnostic tests during the current global wave of COVID-19.

Learning Objectives:

  • To review the available molecular and serological tests used in the management of COVID-19.
  • To share a summary of the UAE testing guidelines and recommendations. 
  • To emphasize the role of a fast and accurate antigen test as a solution in battling the spread of COVID-19 when it can be used in different settings as a diagnostic, screening and surveillance tool.


Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.